BOSTON — Patients with severe alopecia areata treated with baracitinib experienced significant hair regrowth on the scalp, eyelashes and eyebrows, according to a presentation at the American Academy of Dermatology annual meeting.
In this video, Brett A. King, MD, PhD, associate professor of dermatology at Yale School of Medicine, discusses the 52-week pooled analysis of two double-blind, placebo-controlled phase three trials he presented during the meeting’s late-breakers news session.
BRAVE-AA1 and BRAVE-AA2 randomly assigned 1,200 patients with severe alopecia areata to receive